Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

about

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

Item

http://www.wikidata.org/entity/Q36064570

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@ast

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@en

type

Item

label

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@ast

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@en

prefLabel

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@ast

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@en

P1476

Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.

@en

P2093

Giacomo Levantesi

http://www.w3.org/2001/XMLSchema#string

Roberto Marchioli

http://www.w3.org/2001/XMLSchema#string

P2860

Omega 3 fatty acids for prevention and treatment of cardiovascular disease

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Effect of fish oil on arrhythmias and mortality: systematic review.

Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.

Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies.

P304

202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHYS.2012.00202

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228106306

http://www.w3.org/2001/XMLSchema#string

P698

22754534

http://www.w3.org/2001/XMLSchema#string

P932

3385353

http://www.w3.org/2001/XMLSchema#string